Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-24 @ 5:00 PM
Study NCT ID:
NCT04523350
Status:
COMPLETED
Last Update Posted:
2024-12-16
First Post:
2020-08-17
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Instylla HES Hypervascular Tumor Pivotal Study
Sponsor:
Instylla, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-08-17
First Submit QC Date:
None
Study First Post Date:
2020-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-13
Last Update Post Date:
2024-12-16
Last Update Post Date Type:
ACTUAL